Showing 20 of 183 recruiting trials for “hepatocellular-carcinoma”
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
👨⚕️ Eric Roeland, M.D., FAAHPM, FASCO, OHSU Knight Cancer Institute📍 1 site📅 Started Jul 2024View details ↗
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
RecruitingNCT06430983 ↗
Recurrent Liver Cancer: Reconceptualization and Reevaluation
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
RecruitingNCT06548867 ↗
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
🏥 Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started May 2024View details ↗
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
RecruitingNCT06342414 ↗
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)
RecruitingNCT06261047 ↗
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
👨⚕️ jibo yue, dorctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Mar 2024View details ↗
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
👨⚕️ Fabrizio Di Benedetto, University of Modena and Reggio Emilia📍 1 site📅 Started Feb 2024View details ↗
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
National Liver Cancer Screening Trial
👨⚕️ Amit Singal, MD, MS, University of Texas Southwestern Medical Center📍 18 sites📅 Started Dec 2023View details ↗
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
👨⚕️ Tian Zhang, MD, University of Texas Southwestern Medical Center📍 1 site📅 Started Dec 2023View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →